Proponents of the so-called 'sugar diet' are praising it for helping them cut fat while maintaining muscle. Do the claims stack up? A new study investigates.

But in a recent study, researchers investigating one of its compounds, halofuginone (HF), stumbled upon something remarkable.

In recent years, overweight and obesity have become a serious global health problem, posing significant risk factors for ...

Halofuginone can regulate appetite and energy metabolism by increasing the levels of growth differentiation factor 15 (GDF15) ...

Akero Therapeutics' efruxifermin shows strong potential in MASH, especially compensated cirrhosis. Click here to find out why ...

Researchers at Oklahoma University found that the hormone FGF21 can reverse fatty liver disease. The hormone signals the brain to improve liver function. It lowers liver fat and reverses fibrosis.

A new study published in Cell Metabolism reveals how the hormone fibroblast growth factor 21 (FGF21) can reverse fatty liver disease in mice by primarily signaling the brain to improve liver ...

GSK has acquired efimosfermin alfa, a Phase III-ready FGF21 analog from Boston Pharmaceuticals, in a deal valued at up to $2 billion, expanding its hepatology pipeline to target steatotic liver ...

Similar to the family of weight loss drugs known as GLP-1s (glucagon-like peptide 1), which help regulate blood sugar levels and appetite, FGF21 acts on the brain to regulate metabolism.In ...

The webcast of the fireside chats will be accessible in the investor section of 89bio’s website. A replay of the webcasts will be available for approximately 30 days following each conference. 89bio ...

Fibroblast growth factor 21 (FGF21) analogs significantly improve fibrosis and resolve metabolic dysfunction-associated steatohepatitis (MASH) without progression, showing promise for non ...

Apollo Therapeutics Group Ltd. and Sunshine Lake Pharma Co. Ltd. inked a potential $938 million licensing deal for APL-18881 (HEC-88473), Sunshine’s dual fibroblast growth factor 21 ...